Abraham Nudelman

11.8k total citations · 2 hit papers
147 papers, 10.0k citations indexed

About

Abraham Nudelman is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Abraham Nudelman has authored 147 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 64 papers in Organic Chemistry and 22 papers in Oncology. Recurrent topics in Abraham Nudelman's work include Histone Deacetylase Inhibitors Research (27 papers), Cancer therapeutics and mechanisms (15 papers) and Synthesis and Biological Evaluation (11 papers). Abraham Nudelman is often cited by papers focused on Histone Deacetylase Inhibitors Research (27 papers), Cancer therapeutics and mechanisms (15 papers) and Synthesis and Biological Evaluation (11 papers). Abraham Nudelman collaborates with scholars based in Israel, Australia and United States. Abraham Nudelman's co-authors include Hugo E. Gottlieb, Alexander J. M. Miller, John E. Bercaw, Karen I. Goldberg, Brian M. Stoltz, Nathaniel H. Sherden, Ada Rephaeli, Suzanne M. Cutts, Don R. Phillips and Lonnie P. Swift and has published in prestigious journals such as Journal of the American Chemical Society, Blood and PLoS ONE.

In The Last Decade

Abraham Nudelman

147 papers receiving 9.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NMR Chemical Shifts of Trace Impurities: Common Laboratory Solvents, Organics, and Gases in Deuterated Solvents Relevant to the Organometallic Chemist

2010 3.2k citations Abraham Nudelman et al. profile →
NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities

1997 3.2k citations Abraham Nudelman et al. profile →

Peers

Countries citing papers authored by Abraham Nudelman

Since Specialization

Citations

This map shows the geographic impact of Abraham Nudelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham Nudelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham Nudelman more than expected).

Fields of papers citing papers by Abraham Nudelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abraham Nudelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham Nudelman. The network helps show where Abraham Nudelman may publish in the future.

Co-authorship network of co-authors of Abraham Nudelman

This figure shows the co-authorship network connecting the top 25 collaborators of Abraham Nudelman. A scholar is included among the top collaborators of Abraham Nudelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abraham Nudelman. Abraham Nudelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cells 2022 ·Cancer Chemotherapy and Pharmacology ·(unknown), Abraham Nudelman, Ada Rephaeli, Don R. Phillips, Suzanne M. Cutts, Benny J. Evison	2
2	Synthesis and preliminary biological evaluation of gabactyzine, a benactyzine-GABA mutual prodrug, as an organophosphate antidote 2022 ·Scientific Reports ·Michal Weitman, Arik Eisenkraft, Zeev Tashma, (unknown), David Last, Dianne Daniels, David Guez, (unknown), Yael Mardor, Abraham Nudelman, Amir Krivoy	2
3	Comparison of the tissue distribution and metabolism of AN1284, a potent anti-inflammatory agent, after subcutaneous and oral administration in mice 2021 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Michal Weitman, Corina Bejar, Michal L. Melamed, (unknown), (unknown), (unknown), Abraham Nudelman, Marta Weinstock	1
4	Cardioprotection by AN-7, a prodrug of the histone deacetylase inhibitor butyric acid: Selective activity in hypoxic cardiomyocytes and cardiofibroblasts 2020 ·European Journal of Pharmacology ·Vadim Nudelman, Muayad A. Zahalka, Abraham Nudelman, Ada Rephaeli, Gania Kessler‐Icekson	8
5	Effect of Histone Deacetylase Inhibitor, Butyroyloxymethyl-Diethyl Phosphate (AN-7), on Corneal Neovascularization in a Mouse Model 2017 ·Journal of Ocular Pharmacology and Therapeutics ·(unknown), Irit Bahar, Ada Rephaeli, (unknown), Abraham Nudelman, Eitan Livny, Tilda Barliya, Yael Nisgav, Tami Livnat	8
6	Potential Therapeutic Advantages of Doxorubicin when Activated by Formaldehyde to Function as a DNA Adduct-Forming Agent 2015 ·Current Topics in Medicinal Chemistry ·Suzanne M. Cutts, Ada Rephaeli, Abraham Nudelman, (unknown), Don R. Phillips	19
7	Synthesis and in vitro evaluation of anti-inflammatory activity of ester and amine derivatives of indoline in RAW 264.7 and peritoneal macrophages 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Michal Weitman, Abraham Nudelman, Efrat Finkin-Groner, (unknown), (unknown), Donna Schorer-Apelbaum, Marta Weinstock	26
8	Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation 2012 ·Biochemical Pharmacology ·(unknown), Lonnie P. Swift, Ada Rephaeli, Abraham Nudelman, Ken‐ichi Kimura, Don R. Phillips, Suzanne M. Cutts	62
9	Development of Pluronic Micelle-Encapsulated Doxorubicin and Formaldehyde-Releasing Prodrugs for Localized Anticancer Chemotherapy 2009 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·(unknown), (unknown), Abraham Nudelman, Ada Rephaeli, Suzanne M. Cutts, Don R. Phillips	13
10	Carbon nanotubes based electrochemical biosensor for detection of formaldehyde released from a cancer cell line treated with formaldehyde-releasing anticancer prodrugs 2009 ·Bioelectrochemistry ·Lilach Bareket, Ada Rephaeli, (unknown), Abraham Nudelman, Judith Rishpon	39
11	The anticancer prodrugs of butyric acid AN-7 and AN-9, possess antiangiogenic properties 2007 ·Cancer Letters ·(unknown), (unknown), Nataly Tarasenko, Zvi Malik, Abraham Nudelman, Ada Rephaeli	31
12	In vivo efficacy of a novel histone deacetylase inhibitor in combination with radiation for the treatment of gliomas1 2007 ·Neuro-Oncology ·Michal Entin‐Meer, Xiaodong Yang, Scott R. VandenBerg, Kathleen R. Lamborn, Abraham Nudelman, Ada Rephaeli, Daphne A. Haas‐Kogan	45
13	The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity 2007 ·Cancer Chemotherapy and Pharmacology ·Lonnie P. Swift, Suzanne M. Cutts, Abraham Nudelman, (unknown), Ada Rephaeli, Don R. Phillips	32
14	Inhibitors of biotin biosynthesis as potential herbicides: Part 2 2005 ·Pest Management Science ·(unknown), (unknown), Abraham Nudelman, Vernon A. Wittenbach, Dennis H. Flint	5
15	Inhibitors of biotin biosynthesis as potential herbicides 2004 ·Tetrahedron ·(unknown), (unknown), (unknown), Abraham Nudelman, Dennis H. Flint, Vernon A. Wittenbach	21
16	Uptake of pivaloyloxymethyl butyrate into leukemic cells and its intracellular esterase-catalyzed hydrolysis 2000 ·Journal of Cancer Research and Clinical Oncology ·Yael Zimra, Abraham Nudelman, (unknown), (unknown), Mati Shaklai, Adina Aviram, Ada Rephaeli	18
17	Butyric acid and pivaloyloxymethyl butyrate, AN-9, a novel butyric acid derivative, induce apoptosis in HL-60 cells 1997 ·Journal of Cancer Research and Clinical Oncology ·Yael Zimra, Lina Wasserman, Lea Maron, Mati Shaklai, Abraham Nudelman, Ada Rephaeli	30
18	“Vinylogs” and “Acetylenylogs” of β‐Adrenergic Agents 1996 ·Archiv der Pharmazie ·Abraham Nudelman, (unknown), (unknown), (unknown), J. Paul Hieble, Anthony C. Sulpizio	4
19	Broncho dilators 3 4 5 tri hydroxyphenyl ethanolamines 1981 ·Abraham Nudelman, Ronald J. McCaully	2
20	Semisynthetic cephalosporins. III. Synthesis and structure activity relationships of novel orally active 7-[4-hydroxy-3-(substituted methyl)phenyl]-acetamido-3-cephem-4-carboxylic acids.:SYNTHESIS AND STRUCTURE ACTIVITY RELATIONSHIPS OF NOVEL ORALLY ACTIVE 7-[4-HYDROXY-3-(SUBSTITUTED METHYL)PHENYL]-ACETAMIDO-3-CEPHFM-4-CARBOXYLIC ACIDS 1980 ·The Journal of Antibiotics ·Abraham Nudelman, (unknown), (unknown), (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact